1. Home
  2. LEGN vs MTCH Comparison

LEGN vs MTCH Comparison

Compare LEGN & MTCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • MTCH
  • Stock Information
  • Founded
  • LEGN 2014
  • MTCH 1986
  • Country
  • LEGN United States
  • MTCH United States
  • Employees
  • LEGN N/A
  • MTCH N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • MTCH Computer Software: Programming Data Processing
  • Sector
  • LEGN Health Care
  • MTCH Technology
  • Exchange
  • LEGN Nasdaq
  • MTCH Nasdaq
  • Market Cap
  • LEGN 7.0B
  • MTCH 7.3B
  • IPO Year
  • LEGN 2020
  • MTCH 2015
  • Fundamental
  • Price
  • LEGN $32.80
  • MTCH $29.02
  • Analyst Decision
  • LEGN Strong Buy
  • MTCH Buy
  • Analyst Count
  • LEGN 12
  • MTCH 19
  • Target Price
  • LEGN $79.00
  • MTCH $37.74
  • AVG Volume (30 Days)
  • LEGN 1.6M
  • MTCH 5.7M
  • Earning Date
  • LEGN 05-12-2025
  • MTCH 05-08-2025
  • Dividend Yield
  • LEGN N/A
  • MTCH 1.31%
  • EPS Growth
  • LEGN N/A
  • MTCH N/A
  • EPS
  • LEGN N/A
  • MTCH 2.02
  • Revenue
  • LEGN $627,241,000.00
  • MTCH $3,479,373,000.00
  • Revenue This Year
  • LEGN $66.92
  • MTCH $1.05
  • Revenue Next Year
  • LEGN $51.77
  • MTCH $5.15
  • P/E Ratio
  • LEGN N/A
  • MTCH $14.36
  • Revenue Growth
  • LEGN 119.97
  • MTCH 3.41
  • 52 Week Low
  • LEGN $29.27
  • MTCH $26.39
  • 52 Week High
  • LEGN $60.87
  • MTCH $38.84
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 45.92
  • MTCH 44.52
  • Support Level
  • LEGN $29.27
  • MTCH $28.41
  • Resistance Level
  • LEGN $35.11
  • MTCH $29.32
  • Average True Range (ATR)
  • LEGN 1.89
  • MTCH 1.40
  • MACD
  • LEGN 0.16
  • MTCH 0.01
  • Stochastic Oscillator
  • LEGN 60.48
  • MTCH 49.25

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About MTCH Match Group Inc.

Match Group Inc is a provider of online dating products. The company's portfolio of brands includes Tinder, Hinge, Match, Meetic, OkCupid, Pairs, Plenty Of Fish, Azar, BLK, and more, each built to increase its user's likelihood of connecting with others. The company has four operating segments: Tinder, Hinge, Evergreen and Emerging, and Match Group Asia. The company generates the majority of its revenue from the Tinder segment.

Share on Social Networks: